Women with cervicitis. Inflammatory disease of cervix uteri
Conditions
Interventions
Intervention 1: • Intervention group: Participants in this group will receive standard antibiotics including cefixime 400 mg orally (single dose, Kowsar Company) and azithromycin 1 g orally (single do
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Married women of reproductive age 15-45 years. 2) Presence of symptoms of cervicitis including: pain during vaginal intercourse bleeding after vaginal intercourse vaginal itching vaginal burning purulent vaginal mucus discharge erosion (cervical ulcer).
Exclusion criteria
Exclusion criteria: Non-adherence to treatment (the importance of regular treatment will be explained to the research unit and further explanations regarding adherence to treatment will be provided during the telephone call and follow-up). History of pelvic surgery. Pregnancy and breastfeeding. Cervical polyps and fibroids or other diseases related to the cervix. Any cervical malignancy and abnormal cells in a Pap smear test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of cervicitis symptoms. Timepoint: Pre-study, second week, and sixth week assessments. Method of measurement: Questionnaire, Visual Analogue Scale.;Size of the cervical scar. Timepoint: Pre-study, second week, and sixth week assessments. Method of measurement: Visual examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain during vaginal intercourse. Timepoint: Pre-study, the second and sixth weeks of assessment. Method of measurement: Questionnaire, Visual Analogue Scale.;Bleeding after vaginal intercourse. Timepoint: Pre-study, the second and sixth weeks of assessment. Method of measurement: Questionnaire, Visual Analogue Scale.;Vaginal itching. Timepoint: Pre-study, the second and sixth weeks of assessment. Method of measurement: Questionnaire, Visual Analogue Scale.;Vaginal burning. Timepoint: Pre-study, the second and sixth weeks of assessment. Method of measurement: Questionnaire, Visual Analogue Scale.;Vaginal purulent mucous discharge. Timepoint: Pre-study, the second and sixth weeks of assessment. Method of measurement: Questionnaire, Visual Analogue Scale.;Satisfaction. Timepoint: the second and sixth weeks of assessment. Method of measurement: Questionnaire, Visual Analogue Scale.;Number of vaginal intercourses per week. Timepoint: Pre-Study. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Jeddi
Khoram-Abad University of Medical Sciences
Outcome results
None listed